A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...
A study investigated the safety of nephrectomy after exposure to HIF-2α antagonists for localized VHL-deficient kidney cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback